Allogene Therapeutics, Inc. ( ALLO) - Key Metrics
ALLO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | -$0.18 | -$0.13 | -$0.13 |
| 2025Q3 | ? | -$0.19 | -$0.13 | -$0.13 |
| 2025Q2 | ? | -$0.23 | -$0.18 | -$0.18 |
| 2025Q1 | ? | -$0.28 | -$0.25 | -$0.25 |
ALLO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -1.95 |
| 2025Q3 | ? | -1.66 |
| 2025Q2 | ? | -1.21 |
| 2025Q1 | ? | -1.32 |
ALLO
Price: $1.92
52 week price:
Earnings Per Share: -0.77 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 358933
Market Capitalization: 458.5 million